Home > Newsletters > Clinical Trials Advisor > FDA Official: Make Minutes From Agency, Sponsor Meetings Public
Clinical Trials Advisor
Jan. 5, 2012 | Vol. 17 No. 1
FDA Official: Make Minutes From Agency, Sponsor Meetings Public
CDER should be allowed to release minutes from its meetings with sponsors during the drug approval process so that a more accurate account of the interactions is made public and the FDA can defend itself against accusations that it shifted its expectations during reviews, an FDA official says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.